Quantity size:
0.2ml
Concentration:
1mg/ml ERV31包膜蛋白抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its fusogenic properties. It ERV31包膜蛋白抗体can inhibit cell growth through decrease expression of cyclin B1 and increased expression of p21 in vitro. SU mediates receptor recognition.
ERV31包膜蛋白抗体TM anchors the envelope heterodimer to the viral membrane through one transmembrane domain. The other hydrophobic domain, called fusion peptide, mediates fusion of the viral membrane with the target cell membrane.
ERV31包膜蛋白抗体Also known as:
Endogenous retroviral sequence 3; Endogenous retrovirus group 3 member 1; ENR1_HUMAN; Envelope polyprotein; envR; ERV R; ERV-3 envelope protein; ERV-R envelope protein; ERV3 1 envelope protein; ERV3; ERV3 envelope protein; ERV3-1; ERVR; FLJ23884; HERV R; HERV-R envelope protein; HERV-R_7q21.2 provirus ancestral Env polyprotein; HERVR; SU; TM; Transmembrane protein.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ERV31.
●
Predicted Molecular Weight: 68kDa.
ERV31包膜蛋白抗体Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl134Mu01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Po01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Ra01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Rb51肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl134Si01肿瘤坏死因子β(TNFβ)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Beta (TNFb)
kl135Bo01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ca01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ga01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Hu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Mu01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Po01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl135Ra01血小板生成素(TPO)多克隆抗体Polyclonal Antibody to Thrombopoietin (TPO)
kl139Ca01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Hu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Mu01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl139Ra01肿瘤坏死因子相关凋亡诱导配体(TRAIL)多克隆抗体Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
kl140Bo01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Ga01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Hu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Mu01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Po01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Ra01尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
kl140Rb51尿激酶型纤溶酶原激活因子(uPA)多克隆抗体Polyclonal Antibody to Plasminogen Activator, Urokinase (uPA)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话